7th International Symposium on AMD: Age-related Macular Degeneration – Understanding Pathogenetic Mechanisms of Disease
20.09. - 21.09.2019, Baden-Baden
Dissecting AMD: novel approaches
Meeting Abstract
(19amd55)
[Volltext]
Extended follow-up from the IVAN trial
Chakravarthy U, Reeves B, Evans R, Rogers C[Volltext]
Meeting Abstract
(19amd57)
[Volltext]
Developing human based intuitive deep learning algorithms for analyzing intermediate AMD OCT-images
Csaky K, Oulette M, Clark C[Volltext]
Meeting Abstract
(19amd58)
[Volltext]
“Quiescent” CNV in AMD – characteristics and consequences
Querques G, Sacconi R, Capuano V, Carnevali A, Colantuono D, Battista M, Borrelli E, Miere A, Parravano M, Costanzo E, Querques L, Souied EH, Bandello F[Volltext]
Meeting Abstract
(19amd59)
[Volltext]
Type-1 choroidal neovascularization reduces the progression of atrophy in eyes with AMD
Pfau M, von der Emde L, Dysli C, Möller PT, Thiele S, Lindner M, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M[Volltext]
Meeting Abstract
(19amd60)
[Volltext]
Natural history and modulation of drusen by laser: The LEAD randomized controlled trial of sub-threshold nanosecond laser intervention in AMD
Guymer R, LEAD study team[Volltext]
Meeting Abstract
(19amd61)
[Volltext]
10 years anti-VEGF treatment outcomes on neovascular AMD
Gerding H[Volltext]
Meeting Abstract
(19amd62)
[Volltext]
Long-term visual acuity outcomes and anatomic Results: from anti-VEGF therapy in patients with neovascular AMD in a real-life setting
Schumann RG, Deiters V, Günther SR, Vogt D, Siedlecki J, Priglinger SG[Volltext]
Meeting Abstract
(19amd63)
[Volltext]
Long-term incidence of macular atrophy and clinical outcomes in neovascular AMD managed to sub-retinal fluid only
Siedlecki J, Fischer C, Schworm B, Kreutzer TC, Kortüm K, Schumann R, Wolf A, Priglinger SG[Volltext]
